Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Q2 FY24 Earnings Conference Call Transcript Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Un-audited Financial Results for the Quarter and Half Year ended September 30, 2023 Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Investor Presentation
Results Presentation for the quarter and half year ended September 30, 2023 Windlas Biotech Ltd - 543329 - Board Meeting Outcome for Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2023
Un-audited Standalone and Consolidated Financial Results for the Quarter and Half Year ended September 30, 2023 Windlas Biotech Ltd - 543329 - Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2023
Unaudited Financial Results for the quarter and half year ended September 30, 2023. Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Conference Call to discuss financial performance for quarter ended September 30, 2023 Windlas Biotech Ltd - 543329 - Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Wednesday, The November 8, 2023
Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve To inter alia consider and approve the un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2023. Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015